HDAC9 and neoplasm: Histone deacetylase (HDAC) inhibitors exhibit their tumor-suppressive effects by increasing the acetylation of histones and non-histone proteins, thereby regulating gene transcription and leading to the induction of apoptosis, differentiation, and degradation of misfolded proteins [5].